Edition:
United Kingdom

Enanta Pharmaceuticals Inc (ENTA.OQ)

ENTA.OQ on NASDAQ Stock Exchange Global Select Market

101.22USD
19 Feb 2019
Change (% chg)

-- (--)
Prev Close
$101.22
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
102,299
52-wk High
$127.74
52-wk Low
$64.25

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -0.05 September 20 Feb 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 2 2 2 2
(3) HOLD 5 5 5 4
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.71 2.71 2.71 2.67

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 6 41.22 42.67 38.81 26.93
Quarter Ending Jun-19 6 47.50 50.20 44.24 28.15
Year Ending Sep-19 6 219.31 227.00 210.26 150.84
Year Ending Sep-20 6 192.41 214.00 164.00 154.90
Earnings (per share)
Quarter Ending Mar-19 6 -0.05 0.20 -0.32 -0.36
Quarter Ending Jun-19 6 0.05 0.24 -0.30 -0.30
Year Ending Sep-19 6 1.68 2.25 0.81 -0.04
Year Ending Sep-20 6 -0.90 0.40 -1.80 -0.58

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-18 71.27 69.89 1.38 1.94
Quarter Ending Sep-18 69.02 67.21 1.82 2.63
Quarter Ending Jun-18 56.93 57.26 0.33 0.58
Quarter Ending Mar-18 40.77 44.05 3.28 8.05
Quarter Ending Dec-17 31.15 38.11 6.96 22.33
Earnings (per share)
Quarter Ending Dec-18 1.35 1.25 0.10 7.21
Quarter Ending Sep-18 1.19 1.30 0.11 8.94
Quarter Ending Jun-18 0.98 0.97 0.01 1.02
Quarter Ending Mar-18 0.52 0.61 0.09 16.19
Quarter Ending Dec-17 0.19 0.78 0.59 310.53

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 41.22 40.36 38.13 38.76 26.93
Quarter Ending Jun-19 47.50 46.76 42.06 43.05 28.15
Year Ending Sep-19 219.31 217.27 206.39 206.44 150.84
Year Ending Sep-20 192.41 192.41 169.36 162.08 154.90
Earnings (per share)
Quarter Ending Mar-19 -0.05 -0.06 -0.06 -0.02 -0.36
Quarter Ending Jun-19 0.05 0.02 -0.11 -0.08 -0.30
Year Ending Sep-19 1.68 1.63 1.36 1.38 -0.04
Year Ending Sep-20 -0.90 -0.90 -1.11 -1.37 -0.58

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-19 0 0 4 1
Quarter Ending Jun-19 0 0 4 1
Year Ending Sep-19 0 0 4 2
Year Ending Sep-20 0 0 4 0
Earnings
Quarter Ending Mar-19 0 0 2 3
Quarter Ending Jun-19 0 0 3 1
Year Ending Sep-19 0 0 3 3
Year Ending Sep-20 0 0 3 1